NO176570C - Proteinmateriale, inhibin, fremgangsmåte for renfremstilling av dette, antistoff mot inhibin, ikke-terapeutiske blandinger inneholdende inhibin/antistoff samt anvendelse for diagnostiske og analytiske formål - Google Patents
Proteinmateriale, inhibin, fremgangsmåte for renfremstilling av dette, antistoff mot inhibin, ikke-terapeutiske blandinger inneholdende inhibin/antistoff samt anvendelse for diagnostiske og analytiske formålInfo
- Publication number
- NO176570C NO176570C NO860427A NO860427A NO176570C NO 176570 C NO176570 C NO 176570C NO 860427 A NO860427 A NO 860427A NO 860427 A NO860427 A NO 860427A NO 176570 C NO176570 C NO 176570C
- Authority
- NO
- Norway
- Prior art keywords
- inhibin
- protein
- antibody
- purified
- subunits
- Prior art date
Links
- 239000000893 inhibin Substances 0.000 title abstract 12
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 title abstract 12
- 102000004169 proteins and genes Human genes 0.000 title abstract 8
- 108090000623 proteins and genes Proteins 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title abstract 2
- 239000000463 material Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 abstract 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 abstract 2
- 229940028334 follicle stimulating hormone Drugs 0.000 abstract 2
- 238000000338 in vitro Methods 0.000 abstract 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 2
- HBOMLICNUCNMMY-KJFJCRTCSA-N 1-[(4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-KJFJCRTCSA-N 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- 102000009151 Luteinizing Hormone Human genes 0.000 abstract 1
- 108010073521 Luteinizing Hormone Proteins 0.000 abstract 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 102000003946 Prolactin Human genes 0.000 abstract 1
- 108010057464 Prolactin Proteins 0.000 abstract 1
- 229920002684 Sepharose Polymers 0.000 abstract 1
- 102000011923 Thyrotropin Human genes 0.000 abstract 1
- 108010061174 Thyrotropin Proteins 0.000 abstract 1
- 238000004166 bioassay Methods 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
- 210000001733 follicular fluid Anatomy 0.000 abstract 1
- 238000005227 gel permeation chromatography Methods 0.000 abstract 1
- 230000002710 gonadal effect Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 229940040129 luteinizing hormone Drugs 0.000 abstract 1
- 230000002611 ovarian Effects 0.000 abstract 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 abstract 1
- 229940097325 prolactin Drugs 0.000 abstract 1
- 239000013014 purified material Substances 0.000 abstract 1
- 230000002285 radioactive effect Effects 0.000 abstract 1
- 238000003127 radioimmunoassay Methods 0.000 abstract 1
- 238000004007 reversed phase HPLC Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Pregnancy & Childbirth (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Reproductive Health (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Networks Using Active Elements (AREA)
- Centrifugal Separators (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPG542784 | 1984-06-08 | ||
| AUPH003185 | 1985-04-04 | ||
| PCT/AU1985/000119 WO1986000078A1 (en) | 1984-06-08 | 1985-06-03 | Inhibin isolated from ovarian follicular fluid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO860427L NO860427L (no) | 1986-02-06 |
| NO176570B NO176570B (no) | 1995-01-16 |
| NO176570C true NO176570C (no) | 1995-04-26 |
Family
ID=25642809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO860427A NO176570C (no) | 1984-06-08 | 1986-02-06 | Proteinmateriale, inhibin, fremgangsmåte for renfremstilling av dette, antistoff mot inhibin, ikke-terapeutiske blandinger inneholdende inhibin/antistoff samt anvendelse for diagnostiske og analytiske formål |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5102807A (no) |
| EP (1) | EP0185034B1 (no) |
| JP (2) | JP2521707B2 (no) |
| AT (1) | ATE95194T1 (no) |
| CA (1) | CA1341617C (no) |
| DE (1) | DE3587603T2 (no) |
| DK (1) | DK171711B1 (no) |
| NO (1) | NO176570C (no) |
| NZ (1) | NZ212248A (no) |
| WO (1) | WO1986000078A1 (no) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341617C (en) * | 1984-06-08 | 2011-06-28 | Henry George Burger | Inhibin isolated from ovarian follicular fluid |
| WO1986006076A1 (en) | 1985-04-18 | 1986-10-23 | Biotechnology Australia Pty. Ltd. | Recombinant inhibin |
| US5215893A (en) * | 1985-10-03 | 1993-06-01 | Genentech, Inc. | Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| NZ231899A (en) * | 1985-10-03 | 1991-07-26 | Genentech Inc | Human or porcine inhibin peptide compositions and dna encoding them |
| US4798885A (en) * | 1986-02-07 | 1989-01-17 | Genentech, Inc. | Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
| US5089396A (en) * | 1985-10-03 | 1992-02-18 | Genentech, Inc. | Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| US4864019A (en) * | 1985-11-08 | 1989-09-05 | The Salk Institute For Biological Studies | Antibodies to inhibin and conjugates produced therefrom |
| CA1307736C (en) * | 1986-03-13 | 1992-09-22 | David Mark Robertson | Method of assay of inhibin |
| US5015729A (en) * | 1986-06-24 | 1991-05-14 | The Salk Institute For Biological Studies | Ovine inhibin |
| US6150328A (en) * | 1986-07-01 | 2000-11-21 | Genetics Institute, Inc. | BMP products |
| ATE120209T1 (de) * | 1987-01-29 | 1995-04-15 | Biotech Australia Pty Ltd | Isolierung von einkettigen proteinen mit fsh unter- drückender aktivität aus follikularflüssigkeit. |
| US5032507A (en) * | 1987-11-13 | 1991-07-16 | The Salk Institute For Biological Studies | Potentiation of erythropoiesis |
| ATE118351T1 (de) * | 1988-05-31 | 1995-03-15 | Biotech Australia Pty Ltd | Wirkung von hormonen. |
| DE4042408C2 (de) * | 1990-01-08 | 1995-04-06 | Stefan Heiden | Verwendung von Inhibin- neutralisierenden Antikörpern |
| DK0509040T3 (da) * | 1990-01-08 | 1995-04-18 | Genentech Inc | Fremgangsmåde til forøgelse af fertiliteten hos hunkønsvæsener |
| US5942220A (en) * | 1990-03-16 | 1999-08-24 | Chiron Corporation | Inhibitor of cytokine activity and applications thereof |
| KR100259827B1 (ko) * | 1991-11-04 | 2000-06-15 | 브루스 엠. 에이센, 토마스 제이 데스로저 | 재조합 골형태 형성 단백질 헤테로다이머, 그 조성물 및 사용방법 |
| US20080070842A1 (en) * | 1991-11-04 | 2008-03-20 | David Israel | Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| US5428011A (en) * | 1992-06-16 | 1995-06-27 | Procyon Biopharma, Inc. | Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma |
| AU678582B2 (en) * | 1993-05-12 | 1997-06-05 | Genetics Institute, Llc | BMP-11 compositions |
| US6291206B1 (en) * | 1993-09-17 | 2001-09-18 | Genetics Institute, Inc. | BMP receptor proteins |
| CA2176942C (en) | 1993-12-07 | 2011-11-01 | Anthony J. Celeste | Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| US20030171283A1 (en) * | 1994-02-28 | 2003-09-11 | Satterlee Daniel G. | Inhibin compositions and methods of enhancing production performance |
| US5786179A (en) * | 1994-02-28 | 1998-07-28 | Agritech Technologies Ltd. | Heterologous protein comprising avian alpha-subunit inhibin protein and methods of producing same |
| US5725858A (en) * | 1994-02-28 | 1998-03-10 | Agritech Technologies, Ltd. | Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein |
| AU780982B2 (en) * | 1997-04-23 | 2005-04-28 | Monash University | Inhibin modulation of cell growth |
| AUPO638897A0 (en) * | 1997-04-23 | 1997-05-22 | Monash University | Modulation of cell growth and methods relating thereto |
| TW586934B (en) * | 1997-05-19 | 2004-05-11 | Sumitomo Pharma | Immunopotentiating composition |
| US6727224B1 (en) * | 1999-02-01 | 2004-04-27 | Genetics Institute, Llc. | Methods and compositions for healing and repair of articular cartilage |
| DE60012557T2 (de) | 1999-10-15 | 2005-08-04 | Genetics Institute, LLC, Cambridge | Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine |
| CA2355334A1 (en) * | 2000-10-16 | 2002-04-16 | Procyon Biopharma Inc. | Pharmaceutical preparations and methods for inhibiting tumors |
| US20030082233A1 (en) * | 2000-12-01 | 2003-05-01 | Lyons Karen M. | Method and composition for modulating bone growth |
| TW200526779A (en) | 2001-02-08 | 2005-08-16 | Wyeth Corp | Modified and stabilized GDF propeptides and uses thereof |
| CA2449008A1 (en) * | 2001-06-01 | 2002-12-12 | Wyeth | Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins |
| TWI267378B (en) * | 2001-06-08 | 2006-12-01 | Wyeth Corp | Calcium phosphate delivery vehicles for osteoinductive proteins |
| US20050026833A1 (en) * | 2001-11-08 | 2005-02-03 | Rabbani Shafaat Ahmed | PSP-94: use for treatment of hypercalcemia and bone metastasis |
| EA008354B1 (ru) * | 2002-05-17 | 2007-04-27 | Уайз | Инъецируемые твердые переносчики гиалуроновой кислоты для доставки остеогенных протеинов |
| WO2004043287A2 (en) * | 2002-11-07 | 2004-05-27 | Agritech Technology, Ltd | Novel compositions that enhance production performance in avians |
| PL1675608T3 (pl) * | 2003-09-12 | 2007-11-30 | Wyeth Corp | Stałe fosforanowo wapniowe pałeczki do wstrzyknięć dla dostarczania białek osteogennych |
| WO2012074870A2 (en) | 2010-11-29 | 2012-06-07 | Mote Marine Laboratory, Inc. | Fish sexual characteristic determination using peptide hormones |
| BR102014005376A2 (pt) * | 2014-03-07 | 2016-02-10 | Ouro Fino Saúde Animal Ltda | antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1007568A (en) * | 1973-12-13 | 1977-03-29 | Michael C. Attwell | Bovine immunoglobulin isolation process |
| FR2361912A1 (fr) * | 1976-08-19 | 1978-03-17 | Merck & Co Inc | Vaccin anti-fecondite a base de membrane pellucide solubilisee |
| US4409139A (en) * | 1981-08-10 | 1983-10-11 | The Salk Institute For Biological Studies | Gonadostatin |
| US4423037A (en) * | 1982-05-13 | 1983-12-27 | The General Hospital Corporation | Inhibitors of peptide hormone action |
| CA1341617C (en) * | 1984-06-08 | 2011-06-28 | Henry George Burger | Inhibin isolated from ovarian follicular fluid |
| WO1986006076A1 (en) * | 1985-04-18 | 1986-10-23 | Biotechnology Australia Pty. Ltd. | Recombinant inhibin |
| US4624944A (en) * | 1985-06-14 | 1986-11-25 | The Regents Of The University Of California | Human seminal alpha-inhibins |
| US4740587A (en) * | 1985-07-18 | 1988-04-26 | The Salk Institute For Biological Studies | Inhibin and method of purifying same |
| US4798885A (en) * | 1986-02-07 | 1989-01-17 | Genentech, Inc. | Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
| US4864019A (en) * | 1985-11-08 | 1989-09-05 | The Salk Institute For Biological Studies | Antibodies to inhibin and conjugates produced therefrom |
| US4737578A (en) * | 1986-02-10 | 1988-04-12 | The Salk Institute For Biological Studies | Human inhibin |
| ATE118351T1 (de) * | 1988-05-31 | 1995-03-15 | Biotech Australia Pty Ltd | Wirkung von hormonen. |
-
1985
- 1985-05-27 CA CA482470A patent/CA1341617C/en not_active Expired - Fee Related
- 1985-05-30 NZ NZ212248A patent/NZ212248A/en unknown
- 1985-06-03 EP EP85902422A patent/EP0185034B1/en not_active Expired - Lifetime
- 1985-06-03 WO PCT/AU1985/000119 patent/WO1986000078A1/en active IP Right Grant
- 1985-06-03 DE DE85902422T patent/DE3587603T2/de not_active Expired - Lifetime
- 1985-06-03 JP JP60502564A patent/JP2521707B2/ja not_active Expired - Lifetime
- 1985-06-03 AT AT85902422T patent/ATE95194T1/de not_active IP Right Cessation
-
1986
- 1986-02-06 NO NO860427A patent/NO176570C/no unknown
- 1986-02-07 DK DK060586A patent/DK171711B1/da not_active IP Right Cessation
-
1989
- 1989-04-11 US US07/336,053 patent/US5102807A/en not_active Expired - Lifetime
- 1989-08-03 US US07/389,328 patent/US5364837A/en not_active Expired - Lifetime
-
1995
- 1995-03-06 JP JP7084463A patent/JP2583030B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK60586D0 (da) | 1986-02-07 |
| US5102807A (en) | 1992-04-07 |
| DE3587603T2 (de) | 1994-02-10 |
| NO860427L (no) | 1986-02-06 |
| DK60586A (da) | 1986-02-07 |
| DE3587603D1 (de) | 1993-11-04 |
| EP0185034A4 (no) | 1988-01-28 |
| NO176570B (no) | 1995-01-16 |
| JPH0848636A (ja) | 1996-02-20 |
| JPS61502399A (ja) | 1986-10-23 |
| CA1341617C (en) | 2011-06-28 |
| NZ212248A (en) | 1991-05-28 |
| EP0185034A1 (no) | 1986-06-25 |
| DK171711B1 (da) | 1997-04-01 |
| EP0185034B1 (en) | 1993-09-29 |
| JP2583030B2 (ja) | 1997-02-19 |
| ATE95194T1 (de) | 1993-10-15 |
| JP2521707B2 (ja) | 1996-08-07 |
| US5364837A (en) | 1994-11-15 |
| WO1986000078A1 (en) | 1986-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO176570C (no) | Proteinmateriale, inhibin, fremgangsmåte for renfremstilling av dette, antistoff mot inhibin, ikke-terapeutiske blandinger inneholdende inhibin/antistoff samt anvendelse for diagnostiske og analytiske formål | |
| Moss et al. | Hemoglobin synthesis during amphibian metamorphosis: I. Chemical studies on the hemoglobins from the larval and adult stages of Rana catesbeiana | |
| Litman et al. | The evolution of the immune response: VIII. Structural studies of the lamprey immunoglobulin | |
| ROSNER et al. | Purification of corticosteroid-binding globulin from human plasma by affinity chromatography | |
| Manni et al. | The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency | |
| BG60256B1 (bg) | Рекомбинантен метод за получаване на лимфотоксин | |
| STOFFEL et al. | Cell-Free Translation of Human Liver Apolipoprotein AI and All mRNA Processing of Primary Translation Products | |
| Raison et al. | Characterization of immunoglobulin from the Pacific hagfish, a primitive vertebrate | |
| Goldwasser et al. | Further purification of sheep plasma erythropoietin | |
| ATE124703T1 (de) | Verfahren zur trennung von proteinen. | |
| Krystal et al. | Purification of human erythropoietin to homogeneity by a rapid five-step procedure | |
| Stathakis et al. | Human fibrinogen heterogeneities. Preparation and characterization of γ and γ′ chains | |
| AU608216B2 (en) | Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies | |
| Vincent et al. | Characterization of rat α1 microglobulin | |
| Yora et al. | Purification and subfractionation of bovine thyrotropin and lutropin using radioimmunoassays for evaluation of the purification processes | |
| Kobayashi et al. | Carboxymethylcellulose chromatography in 6M urea and zone electrophoresis of calf thymus histone | |
| Murano et al. | An improved method for the preparative isolation of the S-carboxymethyl derivative chains of human fibrinogen | |
| Baldo | Natural'erythrocyte agglutinins in the serum of the Australian freshwater catfish, Tandanus tandanus Mitchell: II. Serum fractionation studies | |
| Acuto et al. | An efficient method for purification of human T-cell growth factor | |
| McEntire | Purification of alpha-2 macroglobulin by immunoadsorbent chromatography | |
| Tamura et al. | Purification and Properties of Whale Thyroid-stimulating Hormone: II. Isolation of Multiple Components | |
| Burger et al. | Method of modifying serum hormone levels using purified inhibin materials | |
| Wong et al. | High-performance liquid chromatography of proteins: Purification of α-fetoprotein from fetal calf serum | |
| Dambuyant et al. | Immunochemical Characteristics of Concanavalin‐A Reactive and Non‐reactive Alpha‐fetoprotein | |
| Hallin et al. | Fractionation of bovine lutropin with the aid of anion-exchange high performance liquid chromatography |